Why changing polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) matters The Daily Nexus
Why changing polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) matters dailynexus.com
Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer Bioengineer.org
Metabolic Enzyme ME1 Emerges as Key to Unlocking Progestin Therapy in Endometrial Cancer bioengineer.org
Endometriosis is a common gynecological disease in which lipid metabolic dysregulation has been increasingly implicated. However, the specific metabolic changes in ectopic lesions and stromal cells remain poorly understood. It …
Interleukin 37 (IL‑37), a member of the IL‑1 family, is recognized as an anti‑inflammatory cytokine. The anti‑inflammatory properties of recombinant human (rh)IL‑37 have been confirmed in vitro and its protective …
Female fertility has long been explained through observation of the ovarian follicle: the number of residing follicles and the quality of the oocyte. This review argues that the tissue surrounding …
Polyendocrine metabolic ovarian syndrome (PMOS) and endometriosis are common gynecological conditions with no cure. Management is aimed at symptom relief with clinical guidelines recommending lifestyle changes including exercise. The aim …
The meiotic spindle is essential for accurate chromosome segregation during oocyte maturation and fertilization, and its alteration might be considered a major contributor to age-related aneuploidy and reproductive failure. Spindle …
Endometriosis is a chronic inflammatory disease characterized by substantial heterogeneity in pain, lesion behavior, and treatment response. Although hormonal and surgical therapies can reduce disease activity and symptoms, their effects …